Hugo A. Katus
Heidelberg University
1553 Papers
9.9K Citations
Hugo A. Katus is an academic researcher from Heidelberg University. The author has contributed to research in topics: Medicine & Myocardial infarction. The author has an hindex of 107, co-authored 1496 publications. Previous affiliations of Hugo A. Katus include University Hospital Heidelberg.
Chat about Author
Papers
Prior smoking status, clinical outcomes, and the comparison of ticagrelor with clopidogrel in acute coronary syndromes—Insights from the PLATelet inhibition and patient Outcomes (PLATO) trial
Jan H. Cornel,Richard C. Becker,Shaun G. Goodman,Steen Husted,Hugo A. Katus,Anwar Santoso,Gabriel Steg,Gabriel Steg,Robert F. Storey,Marius Marcian Vintila,Jie L. Sun,Jay Horrow,Lars Wallentin,Robert A. Harrington,Stefan James +14 more
TL;DR: In patients hospitalized with ACS, habitual smoking is associated with a greater risk of subsequent stent thrombosis and the effects of ticagrelor compared to clopidogrel were consistent for all outcomes regardless of smoking status.
57
Noninvasive Risk Stratification of Patients With Transthyretin Amyloidosis
Arnt V. Kristen,Katrin Scherer,Sebastian J. Buss,Fabian aus dem Siepen,Sabine Haufe,Ralf Bauer,Katrin Hinderhofer,Evangelos Giannitsis,Stefan E. Hardt,Uwe Haberkorn,Hugo A. Katus,Henning Steen +11 more
TL;DR: Quantitative analysis of tracer retention is capable of characterizing the severity of cardiac involvement in ATTR, and troponin T remained the only independent predictor of survival.
57
Comparative efficacy of sodium-glucose cotransporter-2 inhibitors (SGLT2i) for cardiovascular outcomes in type 2 diabetes: a systematic review and network meta-analysis of randomised controlled trials.
Tobias Täger,Dan Atar,Stefan Agewall,Hugo A. Katus,Morten Grundtvig,John G.F. Cleland,Andrew L. Clark,Hanna Fröhlich,Lutz Frankenstein +8 more
TL;DR: Empag liflozin and canagliflozin improved survival with empaglif lozin being superior to the other SGLT2i, and dapaglif Lozin had similar effects on improving worsening HF.
Role of ion channels in heart failure and channelopathies.
TL;DR: The distinct ion channel remodeling processes in HF and in channelopathies associated with HF will be discussed and the basis for improved patient care and individualized therapy based on individualized ion channel composition and remodeling is identified.
57
In-vivo characterization of human dilated cardiomyopathy genes in zebrafish.
Britta Vogel,Benjamin Meder,Steffen Just,Christina Laufer,Ina M. Berger,Sabrina Weber,Hugo A. Katus,Wolfgang Rottbauer +7 more
TL;DR: The results indicate that the zebrafish is a suitable model organism to rapidly evaluate novel DCM disease genes in-vivo and gene-specific differences which are also seen in human DCM can be reliably reproduced in theZebrafish model.
57